Abstract
Background
We present the first case report of the treatment of congenital vaginal atresia by 3D-printed patient-specific vaginal scaffold from China.
Case presentation
A 17-year-old female patient was referred to our department for treatment of congenital vaginal atresia and complications arising from previous failed operations. Pelvic examination was conducted to understand the morphological characteristics and severity of stenosis, and based on which we designed our prototypes of vaginal scaffold using software UG NX10.0. We finally obtained our patient-specific mold, which was 50 mm in length, 28 mm in diameter, 2 mm of thickness with a whole weight of 7.6 g, and it was made of polycaprolactone. After removing scar tissues caused by vaginal stenosis, an 8 cm long artificial tunnel was created, and then the polycaprolactone (PCL) vaginal mold was placed and sutured. The patient had no discomfort after surgery and was discharged 3 days after the surgery. Follow-up for 1 year after surgery, through hysteroscopy and colposcopy, it was found that the cervix was smooth, the vaginal wall was covered with stratified squamous epithelium, and the vaginal wall was soft and lubricated, which was close to a normal vagina. The incompletely absorbed mold was taken out one year after the operation. Hysteroscopy and colposcopy were performed one year and two years after the mold was taken out. The vagina was unobstructed and the length was about 12 cm. The appearance of the vaginal wrinkles was normal. The patient's quality of sexual life was good.
Conclusion
Our team tried to treat congenital vaginal atresia by 3D-printed patient-specific vaginal scaffold, which can effectively reduce patient complications and reduce patient pain. Through long-term follow-up, we found that this technique has achieved favorable results and improved the patient's quality of sexual life.
Keywords: Vaginoplasty, 3D printing, Vaginal mold, Polycaprolactone
Vaginoplasty; 3D printing; Vaginal mold; polycaprolactone.
1. Introduction
The vagina is developed from the pararenal canal and urogenital sinus, which is an important part of the female birth canal and is also critical for sexual life [1]. Abnormal formation and fusion of the pararenal canal and other teratogenic factors can cause vaginal dysplasia, with an incidence of about 1/10000–1/4000 [2]. This is a fairly complex disease that often involves multiple disciplines field. Without effective treatment, congenital vaginal dysplasia will directly affect the sexual life and fertility of these patients, and even have a profound impact on mental health.
Vaginoplasty is undoubtedly the primary method to solve the sexual role and sexual life of these patients who suffer from congenital vaginal atresia and/or vaginal stenosis. The development of vaginoplasty has undergone non-invasive pressure dilatation to transperineal vaginoplasty, transabdominal perineal vaginoplasty and laparoscopic vaginoplasty [3]. However, traditional vaginoplasty has many complications with high failure rate [4, 5]. In fact, the repeated placement and removal of the mold can cause great pain to the patient, and the improper placement of the mold may also lead to operation failure.
Additive Manufacturing (AM), also known as 3D printing, is a revolutionary new technology allowing new shapes and structures to be manufactured that were previously impossible using traditional methods. In particular, for biomedical application, AM emphasizes the dynamic healing and regeneration process of human tissue in medical applications, which can effectively realize tissue self-repair and complete the bionics from structure to function, so it can more truly simulate the dynamic evolution of human microenvironment [6]. In the last few years, 3D printing technique has expanded rapidly in medical applications and health care, especially in customized prosthetics, implants and anatomical molds [7]. There are various AM processes, including stereolithography apparatus, fused deposition modeling, Powder bed fusion, Selective Laser Sintering (SLS), etc [8]. Moreover, the wide range of applications for AM in the biomedical field has been expanded by the biocompatibility of lactic acid-based polymers, such as PCL [9]. PCL is a biodegradable, rigid, and non-toxic polymer that can be manufactured without harmful solvents [10]. Moreover, the physical characteristics (e.g. strength, biodegradability) of PCL are easily manipulated [11]. SLS can be used to produce tissue engineering scaffolds with pre-designed macro and micro features based on computer-aided design models [12]. Here, our team used 3D-printed patient-specific vaginal scaffold for the first time to successfully perform vaginoplasty on a patient with congenital vaginal atresia and severe vaginal stenosis due to four failed surgeries.
2. Case presentation
Informed consent was obtained from patient. A 17-year-old female patient was referred to our department for treatment of congenital vaginal atresia and complications arising from previous failed operations. Gynecological examination revealed that her vulva phenotype was normal and her vagina was atresia. Magnetic resonance imaging of the abdomen and pelvis showed that the ovaries and uterus were normal, the vagina was narrow, and no other congenital abnormalities were found. Karyotype was 46, XX. Previous operations led to formation of cicatrices and severe adhesion between the vagina and peripheral tissues. Moreover, the retention of menstrual blood resulted in repeated infection. Therefore, it was extremely difficult and risky for performing another traditional vaginoplasty and this time may be her last chance. Pelvic examination was conducted to understand the morphological characteristics and severity of stenosis, and based on which we designed our prototypes of vaginal scaffold using software UG NX10.0. After repeated clinical adjustments and modifications, we finally obtained our patient-specific mold, which was 50 mm in length, 28 mm in diameter, 2 mm of thickness with a whole weight of 7.6 g, and it was made of PCL by using SLS (Figure 1A, B). Two copies were printed and biocompatibility was well. Printing parameters: skip capacity: 17.8 L; Print support: None; Laser: Ytterbium-doped fiber laser (EN 60825-1: 2014), 1065 nm, 4.01 mrad full angle; Thermal control: quartz tube heating; Holes: 55 holes with 5 mm diameter. Hole's separation: 7.5 mm. Layer thickness: 0.1 mm.
Figure 1.
Vaginal scaffold model constructed by 3D printing technology. (A) The three-dimensional digital model of vaginal scaffold. (B) The four-dimensional vaginal mold used in the surgery. It was 50 mm in length, 28 mm in diameter, 2 mm of thickness with a semicircular groove, and about 9.5 mm in diameter.
A semicircular groove with a diameter of about 9.5 mm was designed to accommodate the urethra and ensure normal urination. Moreover, the special screen mesh of this mold, on one hand, is beneficial to the tissue adhesion and growth, on the other hand, is convenient to suture and fixation (Figure 2A). By adjusting the molecular weight of PCL, we got our final mold with suitable elastic modulus, and it was set to progressively degrade and completely be absorbed 1–2 years after implanted. This improvement guarantees not only the effectiveness of supporting, meanwhile, the possibility of occurring postoperative complications and the patient's discomfort caused by the mold can also be reduced.
Figure 2.
3D Printing Technique Applied in Vaginoplasty. (A) A view of inside of vagina with the scaffold, it can be seen that the screen mesh helps tissue adhesion. (B) The vaginal scaffold was placed and fixed properly. (C–D) Hysteroscopy was performed 2 days after surgery, the cervical canal and uterine cavity were intact.
After removing scar tissues caused by vaginal stenosis, 20 mL saline solution was injected in anterior and posterior walls of vagina respectively, and the injection point was 2 cm away from the position of scar tissues. Then, respectively, 2 cm of transverse incision was cut in order to dissociate the bladder and rectum from vagina. The gap between bladder and rectum was continuously dissociated until reaching the cervix. The gap was then dilated to about 3.5 cm of width, and finally an 8 cm long of artificial tunnel was created. The PCL vaginal mold was placed in the center of the vagina with the groove directing twelve o'clock, and it was sutured through the mesh at the direction of seven o'clock, ten o'clock, two o'clock and five o'clock (Figure 2B). The patient had no discomfort after the operation. Hysteroscopy was performed 2 days after surgery, the cervical canal and uterine cavity were intact (Figure 2C, D). Three days after the postoperative anti-infection treatment, the patient strongly requested to be discharged from the hospital.
Regular review and follow-up were conducted after discharged from the hospital. Hysteroscopy and colposcopy were performed one month after surgery, the cervical canal and uterine cavity are intact (Figure 3A). Hysteroscopy was performed three month after surgery. The cervix was smooth and the vaginal wall was soft and lubricated (Figure 3B, C). Hysteroscopy and colposcopy were performed 6 months after surgery. The vaginal wall was covered with stratified squamous epithelium, which was close to a normal vagina (Figure 3D).
Figure 3.
Postoperative review results. (A) Hysteroscopy was performed one month after surgery, the cervical canal and the uterine cavity are intact. (B–C) Hysteroscopy and colposcopy were performed three month after surgery. The cervix was smooth and the vaginal wall was soft and lubricated. (D) Hysteroscopy and colposcopy were performed 6 months after surgery. The vaginal wall was covered with stratified squamous epithelium, which was close to a normal vagina.
One year after the operation, the patient felt an increase in vaginal secretions, accompanied by intermittent nocturia and involuntary outflow, then strongly requested to remove the incompletely absorbed mold. Through colposcopy to observe the vaginal wall tissue before and after removing the mold (Figure 4A, B). Hysteroscopy and colposcopy were performed 1 year after the mold was taken out, and the vagina had grown well (Figure 4C). She happily told us that she recently had a boyfriend who loved her very much, and both of them were satisfied with their sex life. Hysteroscopy and colposcopy examination 2 years after the mold was taken out showed that the vagina was unobstructed, about 12 cm in length, capable of holding three fingers, the appearance of the vaginal wrinkles was normal. The cervix was normal in size, and the front and back fornix was shallow (Figure 4D). The Female Sexual Function Index (FSFI) was used to assess the quality of sexual life of this patient [12], and the self-score was 27 points, indicating that the patient's quality of sexual life was good.
Figure 4.
Remove the incompletely absorbed mold and follow up. (A) Vaginal wall tissue before removing the mold. (B) Vaginal wall tissue after removing the mold. (C) Hysteroscopy and colposcopy were performed 1 year after the mold was taken out, and the vagina had grown well. (D)Hysteroscopy and colposcopy examination 2 years after the mold was taken out showed that the vagina was unobstructed, about 12 cm in length, capable of holding three fingers, the appearance of the vaginal wrinkles was normal. The cervix was normal in size, and the front and back fornix was shallow.
3. Discussion
There are many clinical diseases that can be manifested as vaginal hypoplasia, such as Mayer-Rokitansky-Kuster-Hauser syndrome, Complete Androgen Insensitivity Syndrome and vaginal atresia, most of the vaginal hypoplasia is caused by the dysplasia of the accessory mesonephros. Patients are generally obstructed without obstacles, and most of them seek medical treatment due to primary amenorrhea and dyspareunia [13]. In women with vaginal hypoplasia, non-surgical and surgical vaginoplasty treatments are available to lengthen the vagina and facilitate sexual intercourse. Non-surgical vaginal dilation has been recommended as a first-line option, because of its low invasive and high success rate [14]. However, vaginoplasty is considered a suitable surgical option for patients who are poorly compliant and failed dilation therapy, or for those who do not want to undergo vaginal dilatation treatment.
In the past, vaginoplasty usually used autologous tissues, such as the intestine, peritoneum, amnion and mucous. Chiaramonte described a case of vaginoplasty for a little girl using bladder mucosa, then a clinical evaluation was carried out at the age of 18, and it was observed that there was no vaginal introitus stenosis and good cosmetic effects [15]. Another option for vaginal replacement involves the use of an amniotic membrane to provide a neovagina and guide neoepithelialization of the graft. However, the disadvantage is that non sexually active women required long-term vaginal dilation due to rapid retraction of the graft, which is not feasible for women without sex [16].
The rise of tissue engineering has brought hope to vaginal reconstruction, which means the combined use of cells, scaffold materials and biologically active factors to promote tissue repair and regeneration. Using pluripotent stem cells as seed cells combined with degradable scaffolds is a feasible method worth exploring [17]. 3D printing technique allows users to rapidly convert digital 3D models into a biodegradable material implant. In other words, 3D printing is a continuum of 3D printing technology which can print objects that change over time [18]. Some competitive advantages in our case include that 3D computer-assisted design eliminates the need to shape, cut, or contour the implant and this procedure may produce a perfect anatomic fit. Therefore, 3D printing was proved to be applicable, and it showed a promising future of the applications in vaginoplasty and other fields of surgery.
However, both the cost and production time of 3D-printing PCL scaffold are considerable and notable. Moreover, repeated clinical adjustments and modifications make the process in complicated and thus prolong the production time. The last but not the least, although the vaginal mold was accurately designed, we cannot be sure about the outcome including the time of completely degradation, the histological transformation and, most importantly, the restoration of normal function. Therefore, the patient should remain closely follow-up. 3D printing technique is a brand new method for vaginoplasty, which deserves further exploration. It is necessary to establish a thorough regulatory practice and avenue for this technique that involves the materials, physicochemical property, biocompatibility, processing methods and other aspects.
To the best of our knowledge, this is the first case report of the treatment of congenital vaginal atresia by 3D-printed patient-specific vaginal scaffold. Through this technology, the quality of the patient's sexual life is effectively improved. However, this case report also has some limits. Firstly, one year after the operation, due to the strong request of the patient, the 3D printed vaginal mold was taken out before it was completely degraded. It was impossible to observe whether the mold could be completely absorbed. In addition, the mold removal operation will also bring inconvenience to the patient. Secondly, only 3 years after the operation has been followed up, this patient has a stable sexual partner and both are satisfied with their sexual life. Long-term follow-up is still needed in the later period to observe whether this patient can get a normal natural pregnancy and give birth smoothly.
4. Conclusion
Vaginoplasty for patients without vagina or vaginal hypoplasia is a very rare and challenging operation. The optimal treatment requires a multidisciplinary approach, tailored to the individual case, and the surgeon's experience should be considered when planning. 3D printed PCL has excellent biocompatibility, biodegradability, adjustable hardness and degradation time, which can reduce patient complications and avoid the pain caused by removing the mold, and effectively improve the patient's quality of life. In this way, 3D printing technology seems to be a new and ideal vaginoplasty. However, a longer term follow-up is still needed to evaluate the outcome.
Declaration
Author contribution statement
All authors listed have significantly contributed to the investigation, development and writing of this article.
Funding statement
Xiao-ming Zhu was supported by Natural Science Foundation of Shaanxi Province [2021SF-005].
Data availability statement
Data included in article/supp. material/referenced in article.
Declaration of interest's statement
The authors declare no conflict of interest.
Additional information
No additional information is available for this paper.
Acknowledgements
We thank the patient and her families for their consent to publish this report. We sincerely thank all the doctors, nurses and caregivers in our team for their invaluable support and selfless dedication to patient care.
Contributor Information
Tie-sheng Cao, Email: caots4335@126.com.
Xiao-ming Zhu, Email: xiaomingzhu1981@hotmail.com.
References
- 1.Xu S., Zhang J., Wang S., Yang L., Qian J., Yue S., et al. MRI features and differential diagnoses of congenital vaginal atresia. Gynecol. Endocrinol. 2019;35(9):777–781. doi: 10.1080/09513590.2019.1588875. [DOI] [PubMed] [Google Scholar]
- 2.American College of Obstetrics and Gynecology. ACOG committee opinion Nonsurgical diagnosis and management of vaginal agenesis. Number 274, July 2002. Committee on Adolescent Health Care. Int. J. Gynaecol. Obstet. 2002;79(2):167–170. doi: 10.1016/s0020-7292(02)00326-0. [DOI] [PubMed] [Google Scholar]
- 3.Callens N., De Cuypere G., De Sutter P., Monstrey S., Weyers S., Hoebeke P., et al. An update on surgical and non-surgical treatments for vaginal hypoplasia. Hum. Reprod. Update. 2014;20(5):775–801. doi: 10.1093/humupd/dmu024. [DOI] [PubMed] [Google Scholar]
- 4.Acién P., Acién M. The presentation and management of complex female genital malformations. Hum. Reprod. Update. 2016;22(1):48–69. doi: 10.1093/humupd/dmv048. [DOI] [PubMed] [Google Scholar]
- 5.Horbach S.E., Bouman M.B., Smit J.M., Meijerink W.J., van Bodegraven A.A., Mullender M.G. Outcome of vaginoplasty in male-to-female transgenders: a systematic review of surgical techniques. J. Sex. Med. 2015;12(6):1499–1512. doi: 10.1111/jsm.12868. [DOI] [PubMed] [Google Scholar]
- 6.Lui Y.S., Sow W.T., Tan L.P., Lai Y., Li H. 3D printing and stimuli-responsive materials in biomedical aspects. Acta Biomater. 2019;92:19–36. doi: 10.1016/j.actbio.2019.05.005. [DOI] [PubMed] [Google Scholar]
- 7.Zhou W., Qiao Z., Nazarzadeh Zare E., Huang J., Zheng X., Sun X., et al. 3D-Printed dynamic materials in biomedical applications: chemistry, challenges, and their future perspectives in the clinical sector. J. Med. Chem. 2020;63(15):8003–8024. doi: 10.1021/acs.jmedchem.9b02115. [DOI] [PubMed] [Google Scholar]
- 8.Ali M.A., Hu C., Yttri E.A., Panat R. Recent advances in 3D printing of biomedical sensing devices. Adv. Funct. Mater. 2022;32(9) doi: 10.1002/adfm.202107671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Calignano F., Galati M., Iuliano L., Minetola P. Design of additively manufactured structures for biomedical applications: a review of the additive manufacturing processes applied to the biomedical sector. J. Healthcare Eng. 2019;2019 doi: 10.1155/2019/9748212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Labet M., Thielemans W. Synthesis of polycaprolactone: a review. Chem. Soc. Rev. 2009;38(12):3484–3504. doi: 10.1039/b820162p. [DOI] [PubMed] [Google Scholar]
- 11.Zhou Y., Zhou D., Cao P., Zhang X., Wang Q., Wang T., et al. 3D printing of shape memory vascular stent based on βcd-g-polycaprolactone. Macromol. Rapid Commun. 2021 doi: 10.1002/marc.202100176. [DOI] [PubMed] [Google Scholar]
- 12.Chen C.H., Shyu V.B., Chen J.P., Lee M.Y. Selective laser sintered poly-ε-caprolactone scaffold hybridized with collagen hydrogel for cartilage tissue engineering. Biofabrication. 2014;6(1) doi: 10.1088/1758-5082/6/1/015004. [DOI] [PubMed] [Google Scholar]
- 13.Herlin M.K., Petersen M.B., Brännström M. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: a comprehensive update. Orphanet J. Rare Dis. 2020;15(1):214. doi: 10.1186/s13023-020-01491-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Dural Ö., Poyrazoğlu Ş. Conservative management of vaginal hypoplasia. J. Clin. Res. Pediatr. Endocrinol. 2020;12:50–52. doi: 10.4274/jcrpe.galenos.2020.2019.S0222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Chiaramonte C., Vestri E., Tripi F., Giannone A.G., Cimador M., Cataliotti F. Bladder mucosal graft vaginoplasty: a case report. J. Pediatr. Adolesc. Gynecol. 2018;31(5):528–532. doi: 10.1016/j.jpag.2018.06.003. [DOI] [PubMed] [Google Scholar]
- 16.Vatsa R., Bharti J., Roy K.K., Kumar S., Sharma J.B., Singh N., et al. Evaluation of amnion in creation of neovagina in women with Mayer-Rokitansky-Kuster-Hauser syndrome. Fertil. Steril. 2017;108(2):341–345. doi: 10.1016/j.fertnstert.2017.05.026. [DOI] [PubMed] [Google Scholar]
- 17.Zhang X., Liu Z., Yang Y., Yao Y., Tao Y. The clinical outcomes of vaginoplasty using tissue-engineered biomaterial mesh in patients with Mayer-Rokitansky-Küster-Hauser syndrome. Int. J. Surg. 2017;44:9–14. doi: 10.1016/j.ijsu.2017.06.026. [DOI] [PubMed] [Google Scholar]
- 18.Chu H., Yang W., Sun L., Cai S., Yang R., Liang W., et al. 3D printing: a review on recent progresses. Micromachines. 2020;11(9):796. doi: 10.3390/mi11090796. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data included in article/supp. material/referenced in article.
